Clinical, histologic, and ultrastructural features of the corneal dystrophy caused by the R124L, mutation of the BIGH3 gene

被引:24
作者
Dighiero, P
Valleix, S
D'Hermies, F
Drunat, S
Ellies, P
Savoldelli, M
Pouliquen, Y
Delpech, M
Legeais, JM
Renard, G
机构
[1] Hotel Dieu Paris, Dept Ophthalmol, Paris, France
[2] Grp Hosp Cochin, Biochim Genet Lab, Paris, France
关键词
D O I
10.1016/S0161-6420(00)00149-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: This study was designed to describe the clinical, histologic, and ultrastructural features of the corneal dystrophy associated with the R124L mutation of the BIGH3 gene. Design: Retrospective clinical and histologic review of a new genetic mutation. Participants: Thirty-four patients from five unrelated French families with corneal dystrophy caused by the R124L mutation of the BIGH3 gene were studied at the clinical, histologic, and ultrastructural levels. Records of patients carrying this mutation were compared with those from three unrelated patients with corneal dystrophy of Bowman's layer (CDB) type 2 (R555Q mutation) and from three unrelated patients with classic corneal granular dystrophy (R555W mutation). Intervention: The mutational genetic status of the BIGH3 gene was determined for each patient, and the histologic and ultrastructural data available after corneal graft were analyzed. Main Outcomes Measures: Genomic DNA was extracted from peripheral blood leukocytes. Exons 4 and 12 of the BIGH3 gene were amplified by the polymerase chain reaction (PCR), and the PCR products were directly sequenced. Results: All 34 patients with the R124L mutation displayed the clinical, histologic, and electron microscopic features of the dystrophy previously described as a superficial variant of corneal granular dystrophy. Combining molecular genetics with clinical and histologic findings established a clear distinction between the R555Q and R555W dystrophies. Conclusions: The R124L mutation of the BIGH3 gene is associated with specific clinical and morphologic criteria. This indicates that molecular studies are needed for an adequate classification of corneal dystrophies. All criteria are presently available to segregate the dystrophy caused by the R124L mutation (known as CDB1) from the dystrophy caused by the R555Q mutation (known as CDB2). (C) 2000 by the American Academy of Ophthalmology.
引用
收藏
页码:1353 / 1357
页数:5
相关论文
共 18 条
[1]  
AKIYA S, 1970, Archives of Ophthalmology, V84, P179
[2]   A new L527R mutation of the βIGH3 gene in patients with lattice corneal dystrophy with deep stromal opacities [J].
Fujiki, K ;
Hotta, Y ;
Nakayasu, K ;
Yokoyama, T ;
Takano, T ;
Yamaguchi, T ;
Kanai, A .
HUMAN GENETICS, 1998, 103 (03) :286-289
[3]   UNUSUAL SUPERFICIAL VARIANT OF GRANULAR DYSTROPHY OF CORNEA [J].
HADDAD, R ;
FONT, RL ;
FINE, BS .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1977, 83 (02) :213-218
[4]  
Klintworth G K, 1995, Curr Opin Ophthalmol, V6, P44
[5]   Mutation hot spots in 5q31-linked corneal dystrophies [J].
Korvatska, E ;
Munier, FL ;
Djemaï, A ;
Wang, MX ;
Frueh, B ;
Chiou, AGY ;
Uffer, S ;
Ballestrazzi, E ;
Braunstein, RE ;
Forster, RK ;
Culbertson, WW ;
Boman, H ;
Zografos, L ;
Schorderet, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :320-324
[6]  
KUCHLE M, 1995, CORNEA, V14, P333
[7]  
LAIBSON P, 1997, CORNEA, V2, pCH88
[8]  
LOHSE E, 1989, CORNEA, V8, P200
[9]  
Mashima Y, 1999, ARCH OPHTHALMOL-CHIC, V117, P90
[10]  
MOLLER HU, 1989, ACTA OPHTHALMOL, V67, P669